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Background
The Accreditation Council for Graduate Medical Education (ACGME) 
has directed use of Milestones for evaluation of resident performance. 
The objectives of Patient Care Milestone 5: Pharmacotherapy (M5) 
include “possible adverse effects” and “allergies, potential drug-food 
and drug-drug interactions” where a resident ultimately “monitors 
and intervenes in the advent of adverse effects in the ED”. The 
ACGME also has patient safety as a focus of its interim Clinical 
Learning Environment Review (CLER) visits. We present a method 
for resident documentation of M5, with a focus on resident-
observed medication safety themes. 
Methods
After Clinical Competency Committee approval, a PGY 1-4 EM 
program required 1 log per 4-week EM rotation. The electronic form 
was designed with input from core faculty and medical toxicologists. 
The form included multiple-response questions analyzed descriptively 
and free-text fields. A single reviewer qualitatively categorized 
residents’ free-text descriptions into discrete categories for analysis.
Results
From June 2017 to July 2019, 738 reports were submitted by 71  
EM residents. Upon review, 26 were noted as duplicate, incomplete, 
or inappropriately submitted, leaving 712 for analysis. Overall, 663 
(93%) of the encounters occurred in the ED. In 93% (N=665), the 
reporting resident was on an EM rotation at the time of the encounter. 
Overall, 79% (N=560) of the reports involved prescription medications. 
Residents determined that 67% (N=478) of the safety events were 
caused by an adverse reaction to a medication with the most common 
reason for encounter being an adverse response to a patient administered 
medication (N=308, 43%). In 51% (N=362) of cases, treatment was 
administered as a result of the medication error. The most common 
method of prevention that residents identified was prescribing provider 
education (N=229, 32%), followed closely by patient education (N=219, 31%). 
Conclusions
In this single site convenience sample, EM residents appear able to identify 
medication safety events. Data collected through resident submissions 
can not only provide data to evaluate M5 but may reveal local patient 
safety themes for future process improvement projects. Of note, this 
process led to EM residents identifying pharmacologic issues outside of 
the ED, when submission was not required suggesting that it contributed 
to a more general culture of patient safety.712
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